Last reviewed · How we verify

Tozinameran 5 to 11 Years of age (tozinameran-5-to-11-years-of-age)

Pfizer · FDA-approved active Quality 22/100

Tozinameran 5 to 11 Years of age (generic name: tozinameran-5-to-11-years-of-age) is a vaccine drug developed by Pfizer. It is currently FDA-approved for Prevention of COVID-19 in individuals 5 years of age and older.

Tozinameran is a COVID-19 vaccine developed by Pfizer Inc. It works by stimulating the body's immune system to produce antibodies against the SARS-CoV-2 virus. The vaccine is indicated for the prevention of COVID-19 in individuals 5 years of age and older. It has shown significant commercial success, generating $21.2B in revenue. Tozinameran is a novel vaccine, providing a crucial tool in the fight against COVID-19. Its mechanism of action and clinical differentiation set it apart from other vaccines. Its commercial significance and pipeline developments make it a key player in the pharma industry.

At a glance

Generic nametozinameran-5-to-11-years-of-age
SponsorPfizer
Drug classvaccine
TargetSARS-CoV-2 virus
Therapeutic areaImmunology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tozinameran 5 to 11 Years of age

What is Tozinameran 5 to 11 Years of age?

Tozinameran 5 to 11 Years of age (tozinameran-5-to-11-years-of-age) is a vaccine drug developed by Pfizer, indicated for Prevention of COVID-19 in individuals 5 years of age and older.

What is Tozinameran 5 to 11 Years of age used for?

Tozinameran 5 to 11 Years of age is indicated for Prevention of COVID-19 in individuals 5 years of age and older.

Who makes Tozinameran 5 to 11 Years of age?

Tozinameran 5 to 11 Years of age is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Tozinameran 5 to 11 Years of age?

tozinameran-5-to-11-years-of-age is the generic (nonproprietary) name of Tozinameran 5 to 11 Years of age.

What drug class is Tozinameran 5 to 11 Years of age in?

Tozinameran 5 to 11 Years of age belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is Tozinameran 5 to 11 Years of age in?

Tozinameran 5 to 11 Years of age is FDA-approved (marketed).

What does Tozinameran 5 to 11 Years of age target?

Tozinameran 5 to 11 Years of age targets SARS-CoV-2 virus and is a vaccine.

Related